DuPont de Nemours (NYSE:DD) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

DuPont de Nemours (NYSE:DD) released its earnings results on Tuesday. The basic materials company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.48 by $0.07, FiscalAI reports. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter last year, the business earned $1.03 EPS. The business’s revenue was up 4.3% on a year-over-year basis. DuPont de Nemours updated its Q2 2026 guidance to 0.590-0.590 EPS and its FY 2026 guidance to 2.350-2.400 EPS.

Here are the key takeaways from DuPont de Nemours’ conference call:

• Raised full‑year guidance after beating Q1; management now targets ~ $7.185B in net sales at the midpoint and adjusted EPS of $2.35–$2.40 (a $0.10 raise), citing stronger start to the year and Aramids interest income.
• Q1 outperformance — organic sales +2%, operating EBITDA $414M (+15% YoY) with a 24.6% margin (+230 bps), and adjusted EPS $0.55 (reported +53% YoY), driven by favorable mix and productivity gains.
• Bolt‑on capital returns and balance‑sheet action — completed the Aramids divestiture (≈$1.1B net proceeds) and announced a $275M accelerated share repurchase under the existing $2B program, while targeting ~2x leverage and opportunistic M&A.
• Middle East logistics and input‑cost risk — ~ $10M of Q1 Water shipments were delayed and total exposure to the region is ~ $300M (~4% of sales); management expects ~1% pricing/surcharges (~$90M) to offset input cost inflation but flags escalation risk if the conflict worsens.
• Strategic execution and growth drivers — Healthcare strength (high‑single‑digit organic growth), microelectronics/ion‑exchange tailwinds from AI/data‑center demand, new product launches, and an AI collaboration (Uncountable) support medium‑term growth and margin resilience.

DuPont de Nemours Trading Up 1.3%

DuPont de Nemours stock traded up $0.65 during trading on Wednesday, reaching $49.89. The company had a trading volume of 1,904,767 shares, compared to its average volume of 4,271,498. DuPont de Nemours has a 12-month low of $26.82 and a 12-month high of $52.66. The stock’s 50 day moving average price is $46.47 and its two-hundred day moving average price is $43.14. The firm has a market capitalization of $20.45 billion, a price-to-earnings ratio of -26.83, a PEG ratio of 1.57 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.91 and a current ratio of 2.42.

DuPont de Nemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Friday, May 15th. DuPont de Nemours’s payout ratio is presently -43.01%.

Institutional Investors Weigh In On DuPont de Nemours

Several institutional investors have recently bought and sold shares of DD. Palisade Asset Management LLC acquired a new position in shares of DuPont de Nemours during the third quarter worth $26,000. Imprint Wealth LLC acquired a new stake in shares of DuPont de Nemours during the third quarter worth $27,000. Measured Wealth Private Client Group LLC acquired a new stake in shares of DuPont de Nemours during the third quarter worth $30,000. Atlas Capital Advisors Inc. acquired a new stake in shares of DuPont de Nemours in the 4th quarter worth about $38,000. Finally, Ameriflex Group Inc. increased its holdings in shares of DuPont de Nemours by 5,940.0% in the 4th quarter. Ameriflex Group Inc. now owns 1,208 shares of the basic materials company’s stock worth $49,000 after acquiring an additional 1,188 shares during the period. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Zacks Research cut shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Argus reduced their target price on shares of DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating for the company in a research note on Thursday, February 5th. Bank of America reduced their target price on shares of DuPont de Nemours from $50.00 to $47.00 and set a “neutral” rating for the company in a research note on Tuesday, April 21st. Mizuho raised their price objective on shares of DuPont de Nemours from $46.00 to $52.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. Finally, UBS Group raised their price objective on shares of DuPont de Nemours from $49.00 to $56.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Twelve equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $54.57.

DuPont de Nemours News Summary

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: Q1 results beat consensus: adjusted EPS $0.55 vs. $0.48 expected and revenue of ~$1.68B (↑4% YoY); management cited productivity gains and stronger healthcare and aerospace demand as drivers. DD Q1 Earnings Beat
• Positive Sentiment: Company raised FY‑2026 guidance to $2.35–$2.40 adjusted EPS (above street) and guided Q2 EPS ~0.59, giving investors clearer upside to estimates. Q1 Results & Guidance
• Positive Sentiment: Announced a $275M accelerated share repurchase — an immediate capital allocation that reduces float and supports EPS. Buyback Announcement
• Positive Sentiment: Analyst sentiment turned more positive: BMO raised its price target substantially to $60 and kept an outperform rating, which can drive momentum and buying interest. BMO Price Target Move
• Neutral Sentiment: Operations: GAAP income from continuing operations was reported (~$150M) with operating EBITDA of ~$414M and transaction‑adjusted free cash flow of ~$147M — healthy cash conversion but investors will watch sustainability. Operational Metrics
• Neutral Sentiment: Completed the previously announced Aramids divestiture (April 1), simplifying the portfolio; impact on long‑term growth will depend on redeployment of proceeds. Aramids Divestiture
• Negative Sentiment: Near‑term margin/input‑cost risk: commentators note rising input costs tied to geopolitical tensions that could pressure margins if not offset by productivity or pricing. Input Cost Risk
• Negative Sentiment: Despite the beat, some trailing metrics remain mixed (historical net‑margin dynamics and a negative P/E on older periods), so investors should watch whether the improved outlook translates into sustained profitability. Mixed Historical Metrics

About DuPont de Nemours

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.